{"id":409609,"date":"2021-01-06T09:30:16","date_gmt":"2021-01-06T14:30:16","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409609"},"modified":"2021-01-06T09:30:16","modified_gmt":"2021-01-06T14:30:16","slug":"upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/","title":{"rendered":"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">LOS ANGELES<\/span>, <span class=\"xn-chron\">Jan. 6, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3027618-1&amp;h=2799962513&amp;u=https%3A%2F%2Fschallfirm.com%2F&amp;a=The+Schall+Law+Firm\" rel=\"nofollow noopener noreferrer\"><u>The Schall Law Firm<\/u><\/a>, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Minerva Neurosciences, Inc. (&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule <span class=\"xn-money\">10b<\/span>-5 promulgated thereunder by the U.S. Securities and Exchange Commission.<\/p>\n<p>Investors who purchased the Company&#8217;s securities between <span class=\"xn-chron\">May 15, 2017<\/span> and <span class=\"xn-chron\">November 30, 2020<\/span>, inclusive (the &#8221;Class Period&#8221;), are encouraged to contact the firm before <span class=\"xn-chron\">February 8<\/span>, 2021.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/p>\n<p>If you are a shareholder who suffered a loss, <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3027618-1&amp;h=2973408569&amp;u=https%3A%2F%2Fschallfirm.com%2Fcases%2Fminerva-neurosciences-inc%2F%23case-form&amp;a=click+here+to+participate\" rel=\"nofollow noopener noreferrer\">click here to participate<\/a>.<\/p>\n<p>We also encourage you to contact <span class=\"xn-person\">Brian Schall<\/span> of the Schall Law Firm, 2049 Century Park East, Suite 2460, <span class=\"xn-location\">Los Angeles, CA<\/span> 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm&#8217;s website at\u00a0<u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3027618-1&amp;h=2365144382&amp;u=http%3A%2F%2Fpr.report%2FmIwBkOrU&amp;a=www.schallfirm.com\" rel=\"nofollow noopener noreferrer\">www.schallfirm.com<\/a><\/u>, or by email at\u00a0<u><a target=\"_blank\" href=\"mailto:brian@schallfirm.com\" rel=\"nofollow noopener noreferrer\">brian@schallfirm.com<\/a><\/u>.<\/p>\n<p>The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. <\/p>\n<p>According to the Complaint, the Company made false and misleading statements to the market. Minerva failed to inform investors of the true feedback from the FDA after its &#8220;end-of-Phase 2&#8221; meeting. The Company&#8217;s Phase <span class=\"xn-money\">2b<\/span> study failed to use the commercial formulation of roluperidone and was exclusively conducted outside of <span class=\"xn-location\">the United States<\/span>. The Company&#8217;s Phase 3 study was rendered incapable of proving the drug&#8217;s effectiveness due to failing to meet its primary and key secondary endpoints. The Combination of the Phase <span class=\"xn-money\">2b<\/span> and Phase 3 trials would be &#8220;highly unlikely&#8221; to support an NDA submitted to the FDA. Based on these facts, the Company&#8217;s public statements were false and materially misleading throughout the class period. When the market learned the truth about Minerva, investors suffered damages.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/p>\n<p>\n        <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3027618-1&amp;h=1403885483&amp;u=https%3A%2F%2Fschallfirm.com%2Fcases%2Fminerva-neurosciences-inc%2F%23case-form&amp;a=Join+the+case\" rel=\"nofollow noopener noreferrer\">Join the case<\/a>\u00a0to recover your losses.<\/p>\n<p>The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA38908&amp;sd=2021-01-06\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301202042.html\">http:\/\/www.prnewswire.com\/news-releases\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301202042.html<\/a><\/p>\n<p>SOURCE  The Schall Law Firm<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA38908&amp;Transmission_Id=202101060926PR_NEWS_USPR_____LA38908&amp;DateId=20210106\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire LOS ANGELES, Jan. 6, 2021 \/PRNewswire\/ &#8212;\u00a0The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Minerva Neurosciences, Inc. (&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company&#8217;s securities between May 15, 2017 and November 30, 2020, inclusive (the &#8221;Class Period&#8221;), are encouraged to contact the firm before February 8, 2021.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409609","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES, Jan. 6, 2021 \/PRNewswire\/ &#8212;\u00a0The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Minerva Neurosciences, Inc. (&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company&#8217;s securities between May 15, 2017 and November 30, 2020, inclusive (the &#8221;Class Period&#8221;), are encouraged to contact the firm before February 8, 2021.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los &hellip; Continue reading &quot;UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T14:30:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA38908&amp;sd=2021-01-06\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm\",\"datePublished\":\"2021-01-06T14:30:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/\"},\"wordCount\":398,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA38908&amp;sd=2021-01-06\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/\",\"name\":\"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA38908&amp;sd=2021-01-06\",\"datePublished\":\"2021-01-06T14:30:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA38908&amp;sd=2021-01-06\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA38908&amp;sd=2021-01-06\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/","og_locale":"en_US","og_type":"article","og_title":"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk","og_description":"PR Newswire LOS ANGELES, Jan. 6, 2021 \/PRNewswire\/ &#8212;\u00a0The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Minerva Neurosciences, Inc. (&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company&#8217;s securities between May 15, 2017 and November 30, 2020, inclusive (the &#8221;Class Period&#8221;), are encouraged to contact the firm before February 8, 2021.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los &hellip; Continue reading \"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T14:30:16+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA38908&amp;sd=2021-01-06","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm","datePublished":"2021-01-06T14:30:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/"},"wordCount":398,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA38908&amp;sd=2021-01-06","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/","name":"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA38908&amp;sd=2021-01-06","datePublished":"2021-01-06T14:30:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA38908&amp;sd=2021-01-06","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA38908&amp;sd=2021-01-06"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-alert-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-minerva-neurosciences-inc-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Minerva Neurosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409609"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409609\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}